Pharmacokinetics of A New Anti-HIV Ageht: 2′,3′-Dideoxy-2′,3′-Didehydrothymidine (d4T)

Abstract D4T is one of several drugs being considered for antiretroviral therapy in the treatment of AIDS. Pharmacokinetic studies showed that d4T was well absorbed, predominantly eliminated as unchanged drug and able to penetrate the blood-brain barrier.